Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Megan A. Moreno

18 indexed publications match this author name.

ORCID: 0000-0003-2767-0787
OpenAlex: https://openalex.org/A5019764385

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 9 Receptor Pharmacology 9 Review Article 6 Animal Study 6 OCD 5 Mechanism of Action 4 Depression 3 Anxiety 3 Drug Interactions 3 Adverse Events 3 Consciousness 3 Addiction 2

Journals

ClinicalTrials.gov 2 Neuroscience letters 2 Surgical Neurology International 1 Molecules 1 Frontiers in Psychiatry 1 Journal of Psychopharmacology 1 Psychedelic medicine (New Rochelle, N.Y.) 1 Clinical neuropharmacology 1

Publication history

Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitationSurgical Neurology International · 2026-10-09 Preclinical Anxiolytic- and Antidepressant-like Effects of α,α-Trehalose, a Bioactive Compound Identified in Psilocybe cubensisMolecules · 2026-09-23 A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.ClinicalTrials.gov · 2026-07-23 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilizationFrontiers in Psychiatry · 2026-05-13 Psilocybin for Treatment of Obsessive Compulsive DisorderClinicalTrials.gov · 2026-05-12 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.Clinical neuropharmacology · 2025-01-01 Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.Addiction biology · 2022-11-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-08 184. Hallucinogens on TikTokJournal of Adolescent Health · 2022-03-10 Psilocybin for the Treatment of Obsessive-Compulsive Disorders.Current topics in behavioral neurosciences · 2022-01-01 P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-12-01 Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Neuroscience letters · 2013-03-01 Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.Neuroscience letters · 2011-04-15 Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2011-02-02 Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry · 2006-11-01

Author directory